Page last updated: 2024-09-03

arg-3-hyp-7-phe-bradykinin and methoctramine

arg-3-hyp-7-phe-bradykinin has been researched along with methoctramine in 1 studies

Compound Research Comparison

Studies (arg-3-hyp-7-phe-bradykinin)	Trials (arg-3-hyp-7-phe-bradykinin)	Recent Studies (post-2010) (arg-3-hyp-7-phe-bradykinin)	Studies (methoctramine)	Trials (methoctramine)	Recent Studies (post-2010) (methoctramine)
52	2	3	332	1	32

Protein Interaction Comparison

Protein	Taxonomy	methoctramine (IC50)
Cholinesterase	Homo sapiens (human)	0.9772
Muscarinic acetylcholine receptor M2	Homo sapiens (human)	0.0315
Acetylcholinesterase	Homo sapiens (human)	5.3703

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X	1

Other Studies

1 other study(ies) available for arg-3-hyp-7-phe-bradykinin and methoctramine

Article	Year
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship	2008

Article

Year

Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.

Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008